Medical Device News Magazine

New York Bone & Joint Specialists: New Invention Stops or Delays the Progression of Osteoarthritis of the Knee

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

April 1, 2021

New York Bone & Joint Specialists is at the forefront of orthopedic technology, with an exciting invention focused on preventing the development and/or progression of osteoarthritis of the knee.

At the same time, this invention can be used to promote and accelerate the healing of any orthopedically repaired tissue.

Leon E. Popovitz, MD, co-founder of New York Bone & Joint Specialists and top orthopedic surgeon in NYC, has invented a bone and joint implant device that has the potential to counteract the effects of osteoarthritis. As a result, the device would diminish the need for joint replacement surgery, and save billions of dollars in medical costs.

The invention is an anchor that increases blood circulation to soft tissue. It features a unique network of channels that are designed to maximize blood flow and rejuvenate vital structures, such as the meniscus, in a degenerating knee. Thus, a patient who suffers from the beginnings of osteoarthritis of the knee may completely avoid the long and painful process of managing their deteriorating joint and eventually receiving a knee replacement. Instead, their knee may become rejuvenated without the need for joint replacement surgery.

Dr. Popovitz and his team have completed bench testing and cadaver intraoperative testing for this patented implant. Further studies are still in process.

“Millions of people suffer from knee osteoarthritis and millions undergo extensive joint replacement therapy,” says Dr. Popovitz. “My implant serves to replenish circulation to the meniscus, which functions by protecting the knee joint from degeneration. The invention, therefore, works by preserving the knee joint itself.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”